Ken Griffin Twist Bioscience Corp Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 22,900 shares of TWST stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,900
Previous 41,600
44.95%
Holding current value
$1.1 Million
Previous $2.05 Million
49.56%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding TWST
# of Institutions
258Shares Held
66.6MCall Options Held
127KPut Options Held
45.4K-
Artisan Partners Limited Partnership Milwaukee, WI6.02MShares$289 Million0.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$269 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$260 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.36MShares$257 Million2.3% of portfolio
-
Invesco Ltd. Atlanta, GA3.64MShares$175 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.7B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...